학술논문
Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction. An International, Multicenter, Randomized, Placebo-Controlled Trial
Document Type
Article
Author
Source
In: Journal of the American College of Cardiology . (Journal of the American College of Cardiology, 4 November 2008, 52(19):1540-1545)
Subject
Language
English
ISSN
07351097